Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Saliogen Therapeutics, Inc.
*MAILING ADDRESS
1500 District Avenue
*CITY
Burlington
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
01803
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
042
*IDENTIFICATION
Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for
use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery
and development.
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Rachelle A. Dubow, Esq.
ATTORNEY DOCKET NUMBER
126933-0003
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Morgan, Lewis & Bockius LLP
STREET
One Federal Street
CITY
Boston
STATE
Massachusetts
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
02110
PHONE
617-951-8939
FAX
617.341.7701
EMAIL ADDRESS
trademarks@morganlewis.com
OTHER APPOINTED ATTORNEY
the firm of Morgan, Lewis & Bockius LLP, RON N. DREBEN, KAREN A. BUTCHER, ANITA B. POLOTT, CAROLE R. KLEIN, JOSEPH E. WASHINGTON,
KRISTIN H. ALTOFF, DANA S. GROSS, JANE W. WISE, SETH A. RAPPAPORT, CONSTANCE BOUTSIKARIS, REBECCA E. MCDOUGALL, BRITTANY A. ESTELL, RACHEL FERTIG and KIRAN JASSAL, all located at 1111 Pennsylvania
Ave., NW, Washington, D.C. 20004, ROCHELLE D. ALPERT, CARLA B. OAKLEY, SHARON R. SMITH, JENNA STOKES, GENE K. PARK and PETER BYRNE, members of the California Bar, all located at One Market, Spear
Street Tower, San Francisco, California 94105, ANDREW J. GRAY IV, member of the California Bar, located at 1400 Page Mill Road, Palo Alto, California 94304, and RACHELLE A. DUBOW, DAVID O. JOHANSON
and AMELIA G. PENNINGTON, members of the Massachusetts Bar, all located at One Federal Street, Boston, Massachusetts 02110, all of whom should receive correspondence and documents related to this
application through the offices of Morgan, Lewis & Bockius LLP
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90517603
Filing Date:02/08/2021
To the Commissioner for Trademarks:
MARK: GENE CODING (Standard Characters, see mark)
The literal element of the mark consists of GENE CODING. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Saliogen Therapeutics, Inc., a corporation of Delaware, having an address of
1500 District Avenue
Burlington, Massachusetts 01803
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and
veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Rachelle A. Dubow, Esq.. Other appointed attorneys are the firm of Morgan, Lewis & Bockius LLP, RON N. DREBEN, KAREN A. BUTCHER, ANITA B.
POLOTT, CAROLE R. KLEIN, JOSEPH E. WASHINGTON, KRISTIN H. ALTOFF, DANA S. GROSS, JANE W. WISE, SETH A. RAPPAPORT, CONSTANCE BOUTSIKARIS, REBECCA E. MCDOUGALL, BRITTANY A. ESTELL, RACHEL FERTIG and
KIRAN JASSAL, all located at 1111 Pennsylvania Ave., NW, Washington, D.C. 20004, ROCHELLE D. ALPERT, CARLA B. OAKLEY, SHARON R. SMITH, JENNA STOKES, GENE K. PARK and PETER BYRNE, members of the
California Bar, all located at One Market, Spear Street Tower, San Francisco, California 94105, ANDREW J. GRAY IV, member of the California Bar, located at 1400 Page Mill Road, Palo Alto, California
94304, and RACHELLE A. DUBOW, DAVID O. JOHANSON and AMELIA G. PENNINGTON, members of the Massachusetts Bar, all located at One Federal Street, Boston, Massachusetts 02110, all of whom should receive
correspondence and documents related to this application through the offices of Morgan, Lewis & Bockius LLP. Rachelle A. Dubow, Esq. of Morgan, Lewis & Bockius LLP, is a member of the XX
bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
One Federal Street
Boston, Massachusetts 02110
United States
617-951-8939(phone)
617.341.7701(fax)
trademarks@morganlewis.com
The docket/reference number is 126933-0003.
Rachelle A. Dubow, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or
any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Ray Tabibiazar/ Date: 02/05/2021
Signatory's Name: Ray Tabibiazar
Signatory's Position: MD Chairman & CEO
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90517603
Payment Accounting Date: 02/08/2021
Serial Number: 90517603
Internet Transmission Date: Mon Feb 08 11:05:27 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202102081105272
89086-90517603-7608638159ceb227ddb88ae94
c0d6f3de6983efafc8bdb68c1ef842e4801c2aa0
42-DA-05260694-20210205132622611456